References
- Dores GM, Devesa SS, Curtis RE, et al. Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 2012;119:34–43.
- Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood. 2005;106:1154–1163.
- Tian D, Gan S, Xing H, et al. Clinical curative efficacy of inducing remission for the newly diagnosed aged AML patients by chemotherapy with IA and DA regimens. J Exp Hematol. 2014;22:1282–1285.
- Feng S, Cao Z, Wang X. Role of aryl hydrocarbon receptor in cancer. Biochim Biophys Acta. 2013;1836:197–210.
- Nakamura M, Morita A, Seité S, et al. Environment‐induced lentigines: formation of solar lentigines beyond ultraviolet radiation. Exp Dermatol. 2015;24:407–411.
- Wang C, Xu CX, Bu Y, et al. Beta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling. Carcinogenesis. 2013;35:703–713.
- Ray S, Swanson H. Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event? Biochem Pharmacol. 2009;77:681–688.
- Fritz WA, Lin TM, Cardiff RD, et al. The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice. Carcinogenesis. 2006;28:497–505.
- Fan Y, Boivin GP, Knudsen ES, et al. The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res. 2010;70:212–220.
- O’Donnell E, Koch D, Bisson W, et al. The aryl hydrocarbon receptor mediates raloxifene-induced apoptosis in estrogen receptor-negative hepatoma and breast cancer cells. Cell Death Dis. 2014;5:e1038.
- Kolluri SK, Weiss C, Koff A, et al. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 1999;13:1742–1753.
- Murray IA, Patterson AD, Perdew GH. Aryl hydrocarbon receptor ligands in cancer: friend and foe. Nat Rev Cancer. 2014;14:801–814.
- Aggarwal BB, Ichikawa H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle. 2005;4:1201–1215.
- Perez-Chacon G, Martinez-Laperche C, Rebolleda N, et al. Indole-3-carbinol synergizes with and restores fludarabine sensitivity in chronic lymphocytic leukemia cells irrespective of p53 activity and treatment resistances. Clin Cancer Res. 2016;22:134–145.
- Tavasoli B, Ebrahimi S, Manafi R, et al. Indole-3-carbinol induces G1 cell cycle arrest in pre-B acute lymphoblastic leukemia cell line. J Arak Univ Med Sci. 2014;17:30–40.
- Safa M, Tavasoli B, Manafi R, et al. Indole-3-carbinol suppresses NF-κB activity and stimulates the p53 pathway in pre-B acute lymphoblastic leukemia cells. Tumour Biol. 2015;36:3919–3930.
- Bai LY, Weng JR, Chiu CF, et al. OSU-A9, an indole-3-carbinol derivative, induces cytotoxicity in acute myeloid leukemia through reactive oxygen species-mediated apoptosis. Biochem Pharmacol. 2013;86:1430–1440.
- Bunaciu RP, Yen A. Activation of the aryl hydrocarbon receptor AhR promotes retinoic acid-induced differentiation of myeloblastic leukemia cells by restricting expression of the stem cell transcription factor Oct4. Cancer Res. 2011;71:2371–2380.
- Lindsey S, Papoutsakis ET. The evolving role of the aryl hydrocarbon receptor (AHR) in the normophysiology of hematopoiesis. Stem Cell Rev. 2012;8:1223–1235.
- Park E, Jung H, Yang H, et al. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res. 2007;56:45–50.
- Mohammadi S, Seyedhoseini FS, Asadi J, et al. Effects of berberine on the secretion of cytokines and expression of genes involved in cell cycle regulation in THP-1 monocytic cell line. Iran J Basic Med Sci. 2017;20:530–537.
- Jazi MS, Mohammadi S, Yazdani Y, et al. Effects of valproic acid and pioglitazone on cell cycle progression and proliferation of T-cell acute lymphoblastic leukemia Jurkat cells. Iran J Basic Med Sci. 2016;19:779.
- Javaheri-Kermani M, Farazmandfar T, Ajami A, et al. Impact of hepcidin antimicrobial peptide on iron overload in tuberculosis patients. Scand J Infect Dis. 2014;46:693–696.
- Yazdani Y, Keyhanvar N, Kalhor HR, et al. Functional analyses of recombinant mouse hepcidin-1 in cell culture and animal model. Biotechnol Lett. 2013;35:1191–1197.
- Boitano AE, Wang J, Romeo R, et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science. 2010;329:1345–1348.
- Minsavage GD, Park SK, Gasiewicz TA. The aryl hydrocarbon receptor (AhR) tyrosine 9, a residue that is essential for AhR DNA binding activity, is not a phosphoresidue but augments AhR phosphorylation. J Biol Chem. 2004;279:20582–20593.
- Wu TY, Saw CLL, Khor TO, et al. In vivo pharmacodynamics of indole‐3‐carbinol in the inhibition of prostate cancer in transgenic adenocarcinoma of mouse prostate (TRAMP) mice: involvement of Nrf2 and cell cycle/apoptosis signaling pathways. Mol Carcinog. 2012;51:761–770.
- Nguyen PL, Taghian AG, Katz MS, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol. 2008;26:2373–2378.
- Xie Y, Tokay T, Zhumadilov Z, et al. Natural (tryptophan) metabolites—mediated activation of aryl hydrocarbon receptor inhibits cancer stem cell signaling: what does it mean to prevent cancer recurrence? Transl Cancer Res. 2016;5:64–67.
- Shen M, Bunaciu RP, Congleton J, et al. Interferon regulatory factor-1 binds c-Cbl, enhances mitogen activated protein kinase signaling and promotes retinoic acid-induced differentiation of HL-60 human myelo-monoblastic leukemia cells. Leuk Lymphoma. 2011;52:2372–2379.
- Hinterleitner C, Huelsenbeck J, Henninger C, et al. Rac1 signaling protects monocytic AML cells expressing the MLL-AF9 oncogene from caspase-mediated apoptotic death. Apoptosis. 2013;18:963–979.
- Choi HS, Cho MC, Lee HG, et al. Indole-3-carbinol induces apoptosis through p53 and activation of caspase-8 pathway in lung cancer A549 cells. Food Chem Toxicol. 2010;48:883–890.
- Yoo G, Allred CD. The estrogenic effect of trigonelline and 3,3-diindolymethane on cell growth in non-malignant colonocytes. Food Chem Toxicol. 2016;87:23–30.
- Ouyang L, Shi Z, Zhao S, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 2012;45:487–498.
- Chinni SR, Li Y, Upadhyay S, et al. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene. 2001;20:2927–2936.
- Kundu A, Quirit JG, Khouri MG, et al. Inhibition of oncogenic BRAF activity by indole‐3‐carbinol disrupts microphthalmia‐associated transcription factor expression and arrests melanoma cell proliferation. Mol Carcinog. 2016;56:49–61.
- Chen Z, Tao ZZ, Chen SM, et al. Indole-3-carbinol inhibits nasopharyngeal carcinoma growth through cell cycle arrest in vivo and in vitro. PLoS One. 2013;8:e82288.